Key facts
- This page summarizes Daniel E. Geffken's Form 3 filing for ProMIS Neurosciences Inc. (PMN).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2022, 19:28.
Daniel E. Geffken - 07 Jul 2022 Form 3 Insider Report for ProMIS Neurosciences Inc. (PMN)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- PMN
- Reported as of
- 07 Jul 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Jul 2022, 19:28:19 UTC
- Prior SEC filing
- 09 Jun 2022
- Next SEC filing
- 03 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason L. Langford, Attorney-in-Fact for Daniel E. Geffken
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel E. Geffken filed Form 3 for ProMIS Neurosciences Inc. (PMN) on 07 Jul 2022.
Change
- Previous filing in this sequence was filed on 09 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMN
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,852
- Date
- 07 Jul 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PMN
holding
Derivative
Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 07 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 8,333
- Exercise price
- $10.80
- Footnotes
- F1, F2
PMN
holding
Derivative
Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 07 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 8,333
- Exercise price
- $10.80
- Footnotes
- F1, F3
PMN
holding
Derivative
Warrants (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 07 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 1,042
- Exercise price
- $18.00
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Conversion or exercise price is in Canadian dollars.
Footnote F2
The option agreement provides that 20% of the options vested immediately, with the balance vesting ratably over 36 months. The option was granted on March 1, 2017.
Footnote F3
The option agreement provides that the options become exercisable in twelve equal monthly installments beginning one month after the grant. The option was granted on November 12, 2021.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney